Role of α6 nicotinic receptors in CNS dopaminergic function: Relevance to addiction and neurological disorders

Biochemical Pharmacology

Volumn 82, Issue 8, 2011, Pages 873-882

  Quik, Maryka ^a   Perez, Xiomara A ^a   Grady, Sharon R ^b  

^a SRI INTERNATIONAL   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Addiction; Cyclic voltammetry; Nucleus accumbens; Parkinson's disease; Striatum

Indexed keywords

ACETYLCHOLINE; ALCOHOL; LEVODOPA; MESSENGER RNA; NICOTINE; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR ALPHA6; NICOTINIC RECEPTOR ALPHA6BETA2BETA3; TRITIUM; UNCLASSIFIED DRUG; VARENICLINE;

ADDICTION; ALCOHOL CONSUMPTION; ALCOHOLISM; CONFERENCE PAPER; CORPUS STRIATUM; CYCLIC POTENTIOMETRY; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DYSKINESIA; HUMAN; LOCOMOTION; MESOLIMBIC DOPAMINERGIC SYSTEM; MOTOR CONTROL; NEUROLOGIC DISEASE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; REINFORCEMENT; REWARD; SMOKING; TOBACCO DEPENDENCE; VISUAL SYSTEM;

ANIMALS; CENTRAL NERVOUS SYSTEM; CORPUS STRIATUM; DOPAMINE; HUMANS; NUCLEUS ACCUMBENS; PARKINSON DISEASE; PROTEIN SUBUNITS; RECEPTORS, NICOTINIC; SUBSTANCE-RELATED DISORDERS; VISUAL CORTEX;

EID: 80052034851     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2011.06.001     Document Type: Conference Paper

References (142)

1. E.X. Albuquerque, E.F. Pereira, M. Alkondon, and S.W. Rogers Mammalian nicotinic acetylcholine receptors: from structure to function Physiol Rev 89 2009 73 120
2. J.P. Changeux, M. Kasai, and C.Y. Lee Use of a snake venom toxin to characterize the cholinergic receptor protein Proc Natl Acad Sci USA 67 1970 1241 1247
3. J. Boulter, J. Connolly, E. Deneris, D. Goldman, S. Heinemann, and J. Patrick Functional expression of two neuronal nicotinic acetylcholine receptors from cDNA clones identifies a gene family Proc Natl Acad Sci USA 84 1987 7763 7767
4. J. Boulter, K. Evans, D. Goldman, G. Martin, D. Treco, and S. Heinemann Isolation of a cDNA clone coding for a possible neural nicotinic acetylcholine receptor alpha-subunit Nature 319 1986 368 374 (Pubitemid 16163895)
5. J. Boulter, W. Luyten, K. Evans, P. Mason, M. Ballivet, and D. Goldman Isolation of a clone coding for the alpha-subunit of a mouse acetylcholine receptor J Neurosci 5 1985 2545 2552 (Pubitemid 15226947)
6. Lamar E, Miller K, Patrick JW. Society for Neuroscience Abstracts; 1990.
7. K.C. Yang, G.Z. Jin, and J. Wu Mysterious alpha6-containing nAChRs: function, pharmacology, and pathophysiology Acta Pharmacol Sin 30 2009 740 751
8. A.R. Tapper alpha6-containing nicotinic receptros unmasked in vivo: selective dopaminergic neuronal expression and activation in motor and reward pathways Cell Sci 5 2009 1742 1752
9. P. Calabresi, and M. Di Filippo ACh/dopamine crosstalk in motor control and reward: a crucial role for alpha 6-containing nicotinic receptors? Neuron 60 2008 4 7
10. M. Quik, and J.M. McIntosh Striatal alpha6* nicotinic acetylcholine receptors: potential targets for Parkinson's disease therapy J Pharmacol Exp Ther 316 2006 481 489 (Pubitemid 43130973)
11. N.S. Millar, and C. Gotti Diversity of vertebrate nicotinic acetylcholine receptors Neuropharmacology 56 2009 237 246
12. N. Champtiaux, Z.Y. Han, A. Bessis, F.M. Rossi, M. Zoli, and L. Marubio Distribution and pharmacology of alpha 6-containing nicotinic acetylcholine receptors analyzed with mutant mice J Neurosci 22 2002 1208 1217 (Pubitemid 34163722)
13. N. Le Novere, M. Zoli, and J.P. Changeux Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain Eur J Neurosci 8 1996 2428 2439 (Pubitemid 26387904)
14. M. Quik, Y. Polonskaya, A. Gillespie, M. Jakowec, G.K. Lloyd, and J.W. Langston Localization of nicotinic receptor subunit mRNAs in monkey brain by in situ hybridization J Comp Neurol 425 2000 58 69
15. Marks M. unpublished.
16. Z.Y. Han, N. Le Novere, M. Zoli, J.A. Hill Jr, N. Champtiaux, and J.P. Changeux Localization of nAChR subunit mRNAs in the brain of Macaca mulatta Eur J Neurosci 12 2000 3664 3674
17. E. Wada, K. Wada, J. Boulter, E. Deneris, S. Heinemann, and J. Patrick Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: A hybridization histochemical study in the rat J Comp Neurol 284 1989 314 335 (Pubitemid 19185398)
18. G.E. Cartier, D. Yoshikami, W.R. Gray, S. Luo, B.M. Olivera, and J.M. McIntosh A new alpha-conotoxin which targets alpha3beta2 nicotinic acetylcholine receptors J Biol Chem 271 1996 7522 7528 (Pubitemid 26107027)
19. N. Champtiaux, C. Gotti, M. Cordero-Erausquin, D.J. David, C. Przybylski, and C. Lena Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice J Neurosci 23 2003 7820 7829 (Pubitemid 37055453)
20. M. Zoli, M. Moretti, A. Zanardi, J.M. McIntosh, F. Clementi, and C. Gotti Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum J Neurosci 22 2002 8785 8789 (Pubitemid 35379047)
21. P. Whiteaker, J.M. McIntosh, S. Luo, A.C. Collins, and M.J. Marks 125I-alpha-conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain Mol Pharmacol 57 2000 913 925 (Pubitemid 30253374)
22. M. Quik, Y. Polonskaya, J.M. Kulak, and J.M. McIntosh Vulnerability of 125I-alpha-conotoxin MII binding sites to nigrostriatal damage in monkey J Neurosci 21 2001 5494 5500 (Pubitemid 32692147)
23. C. Gotti, M. Moretti, A. Zanardi, A. Gaimarri, N. Champtiaux, and J.P. Changeux Heterogeneity and selective targeting of neuronal nicotinic acetylcholine receptor (nAChR) subtypes expressed on retinal afferents of the superior colliculus and lateral geniculate nucleus: identification of a new native nAChR subtype alpha3beta2(alpha5 or beta3) enriched in retinocollicular afferents Mol Pharmacol 68 2005 1162 1171 (Pubitemid 41348716)
24. B.C. Cox, A.M. Marritt, D.C. Perry, and K.J. Kellar Transport of multiple nicotinic acetylcholine receptors in the rat optic nerve: high densities of receptors containing alpha6 and beta3 subunits J Neurochem 105 2008 1924 1938 (Pubitemid 351678506)
25. J. Liu, A.M. McGlinn, A. Fernandes, A.H. Milam, C.E. Strang, and M.E. Andison Nicotinic acetylcholine receptor subunits in rhesus monkey retina Invest Ophthalmol Vis Sci 50 2009 1408 1415
26. S.R. Grady, M. Moretti, M. Zoli, M.J. Marks, A. Zanardi, and L. Pucci Rodent habenulo-interpeduncular pathway expresses a large variety of uncommon nAChR subtypes. But only the {alpha}3{beta}4 and {alpha}3{beta}3{beta}4 subtypes mediate acetylcholine release J Neurosci 29 2009 2272 2282
27. M. Quik, S. Vailati, T. Bordia, J.M. Kulak, H. Fan, and J.M. McIntosh Subunit composition of nicotinic receptors in monkey striatum: effect of treatments with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine or l-DOPA Mol Pharmacol 67 2005 32 41 (Pubitemid 40073630)
28. C. Gotti, S. Guiducci, V. Tedesco, S. Corbioli, L. Zanetti, and M. Moretti Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement J Neurosci 30 2010 5311 5325
29. C. Cui, T.K. Booker, R.S. Allen, S.R. Grady, P. Whiteaker, and M.J. Marks The beta3 nicotinic receptor subunit: a component of alpha-conotoxin MII-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors J Neurosci 23 2003 11045 11053 (Pubitemid 37548938)
30. C. Gotti, M. Moretti, F. Clementi, L. Riganti, J.M. McIntosh, and A.C. Collins Expression of nigrostriatal alpha 6-containing nicotinic acetylcholine receptors is selectively reduced, but not eliminated, by beta 3 subunit gene deletion Mol Pharmacol 67 2005 2007 2015 (Pubitemid 41007782)
31. C. Gotti, F. Clementi, A. Fornari, A. Gaimarri, S. Guiducci, and I. Manfredi Structural and functional diversity of native brain neuronal nicotinic receptors Biochem Pharmacol 78 2009 703 711
32. T. Bordia, S.R. Grady, J.M. McIntosh, and M. Quik Nigrostriatal damage preferentially decreases a subpopulation of {alpha}6{beta}2* nAChRs in mouse, monkey and Parkinson's disease striatum Mol Pharmacol 72 2007 52 61 (Pubitemid 46998524)
33. P.D. Livingstone, and S. Wonnacott Nicotinic acetylcholine receptors and the ascending dopamine pathways Biochem Pharmacol 78 2009 744 755
34. S.R. Grady, K.L. Murphy, J. Cao, M.J. Marks, J.M. McIntosh, and A.C. Collins Characterization of nicotinic agonist-induced [(3)H]dopamine release from synaptosomes prepared from four mouse brain regions J Pharmacol Exp Ther 301 2002 651 660 (Pubitemid 34429981)
35. M. Moretti, S. Vailati, M. Zoli, G. Lippi, L. Riganti, and R. Longhi Nicotinic acetylcholine receptor subtypes expression during rat retina development and their regulation by visual experience Mol Pharmacol 66 2004 85 96 (Pubitemid 38822090)
36. M.F. Giorguieff, M.L. Le Floc'h, T.C. Westfall, J. Glowinski, and M.J. Besson Nicotinic effect of acetylcholine on the release of newly synthesized (3H)dopamine in rat striatal slices and cat caudate nucleus Brain Res 106 1976 117 131
37. C. Rapier, G.G. Lunt, and S. Wonnacott Stereoselective nicotine-induced release of dopamine from striatal synaptosomes: concentration dependence and repetitive stimulation J Neurochem 50 1988 1123 1130
38. S. Grady, M.J. Marks, S. Wonnacott, and A.C. Collins Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum J Neurochem 59 1992 848 856
39. P.P. Rowell, L.A. Carr, and A.C. Garner Stimulation of [3H]dopamine release by nicotine in rat nucleus accumbens J Neurochem 49 1987 1449 1454 (Pubitemid 17161365)
40. S.A. Kaiser, L. Soliakov, S.C. Harvey, C.W. Luetje, and S. Wonnacott Differential inhibition by alpha-conotoxin-MII of the nicotinic stimulation of [3H]dopamine release from rat striatal synaptosomes and slices J Neurochem 70 1998 1069 1076 (Pubitemid 28113640)
41. J.M. Kulak, T.A. Nguyen, B.M. Olivera, and J.M. McIntosh Alpha-conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes J Neurosci 17 1997 5263 5270 (Pubitemid 127777368)
42. S. McCallum, N. Parameswaran, T. Bordia, H. Fan, M. McIntosh, and M. Quik Differential regulation of mesolimbic {alpha}3*/{alpha}6{beta}2* and {alpha}4{beta}2* nAChR sites and function after long-term oral nicotine to monkeys J Pharmacol Exp Ther 318 2006 381 388 (Pubitemid 43922326)
43. S.E. McCallum, N. Parameswaran, T. Bordia, J.M. McIntosh, S.R. Grady, and M. Quik Decrease in alpha3*/alpha6* nicotinic receptors but not nicotine-evoked dopamine release in monkey brain after nigrostriatal damage Mol Pharmacol 68 2005 737 746 (Pubitemid 41206027)
44. R. Exley, M.A. Clements, H. Hartung, J.M. McIntosh, and S.J. Cragg alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens Neuropsychopharmacology 33 2008 2158 2166 (Pubitemid 351992087)
45. R. Exley, and S.J. Cragg Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission Br J Pharmacol 153 Suppl. 1 2008 S283 S297
46. E.L. Meyer, D. Yoshikami, and J.M. McIntosh The neuronal nicotinic acetylcholine receptors alpha 4* and alpha 6* differentially modulate dopamine release in mouse striatal slices J Neurochem 105 2008 1761 1769 (Pubitemid 351678494)
47. X. Perez, K. O'Leary, N. Parameswaran, J.M. McIntosh, and M. Quik Prominent role of {alpha}3/{alpha}6{beta}2* nAChRs in regulating evoked dopamine release in primate putamen; effect of long-term nicotine treatment Mol Pharmacol 75 2009 938 946
48. X.A. Perez, T. Bordia, J.M. McIntosh, S.R. Grady, and M. Quik Long-term nicotine treatment differentially regulates striatal alpha6alpha4beta2* and alpha6(nonalpha4)beta2* nAChR expression and function Mol Pharmacol 74 2008 844 853
49. X.A. Perez, T. Bordia, J.M. McIntosh, and M. Quik {Alpha}6{beta}2* and {alpha}4{beta}2* nicotinic receptors both regulate dopamine signaling with increased nigrostriatal damage: relevance to Parkinson's disease Mol Pharmacol 78 2010 971 980
50. X.A. Perex, J. Ly, J.M. McIntosh, and M. Quik Chronic nicotine exposure desensitizes dopaminergic function in the nucleus accumbens Nicotinic Acetylcholine Receptor Conference 2 2011 43
51. M.E. Rice, and S.J. Cragg Nicotine amplifies reward-related dopamine signals in striatum Nat Neurosci 7 2004 583 584 (Pubitemid 38691894)
52. H. Zhang, and D. Sulzer Frequency-dependent modulation of dopamine release by nicotine Nat Neurosci 7 2004 581 582 (Pubitemid 38691893)
53. T. Zhang, L. Zhang, Y. Liang, A.G. Siapas, F.M. Zhou, and J.A. Dani Dopamine signaling differences in the nucleus accumbens and dorsal striatum exploited by nicotine J Neurosci 29 2009 4035 4043
54. S. Threlfell, M.A. Clements, T. Khodai, I.S. Pienaar, R. Exley, and J. Wess Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum J Neurosci 30 2010 3398 3408
55. A. Kuryatov, and J.M. Lindstrom Expression of functional human {alpha}6{beta}2{beta}3* in xenopus oocytes achieved through subunit chimeras and concatamers Mol Pharmacol 79 2010 126 140
56. M.R. Picciotto, N.A. Addy, Y.S. Mineur, and D.H. Brunzell It is not "either/or": activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood Prog Neurobiol 84 2008 329 342
57. J.J. Buccafusco, J.W. Beach, and A.V. Terry Desensitization of nicotinic acetylcholine receptors as a strategy for drug development J Pharmacol Exp Ther 328 2009 364 370
58. A.P. Govind, P. Vezina, and W.N. Green Nicotine-induced upregulation of nicotinic receptors: underlying mechanisms and relevance to nicotine addiction Biochem Pharmacol 78 2009 756 765
59. N.L. Benowitz Neurobiology of nicotine addiction: implications for smoking cessation treatment Am J Med 121 2008 S3 S10
60. M.J. Marks, J.B. Burch, and A.C. Collins Effects of chronic nicotine infusion on tolerance development and nicotinic receptors J Pharmacol Exp Ther 226 1983 817 825 (Pubitemid 13007732)
61. M.E. Benwell, D.J. Balfour, and J.M. Anderson Evidence that tobacco smoking increases the density of (-)-[3H]nicotine binding sites in human brain J Neurochem 50 1988 1243 1247
62. M.J. Marks, J.R. Pauly, S.D. Gross, E.S. Deneris, I. Hermans-Borgmeyer, and S.F. Heinemann Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment J Neurosci 12 1992 2765 2784
63. S.E. McCallum, N. Parameswaran, T. Bordia, H. Fan, R.F. Tyndale, and J.W. Langston Increases in alpha4* but not alpha3*/alpha6* nicotinic receptor sites and function in the primate striatum following chronic oral nicotine treatment J Neurochem 96 2006 1028 1041
64. J.R. Pauly, M.J. Marks, S.F. Robinson, J.L. van de Kamp, and A.C. Collins Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing alpha 4 or beta 2 mRNA levels J Pharmacol Exp Ther 278 1996 361 369 (Pubitemid 27167115)
65. D.C. Perry, M.I. Davila-Garcia, C.A. Stockmeier, and K.J. Kellar Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies J Pharmacol Exp Ther 289 1999 1545 1552 (Pubitemid 29246689)
66. M. Marks, T. McClure-Begley, P. Whiteaker, O. Salminen, R. Brown, and J. Cooper Increased nicotinic acetylcholine receptor protein underlies chronic nicotine-induced up-regulation of nicotinic agonist binding sites in mouse brain J Pharmacol Exp Ther 337 2011 187 200
67. R.D. Schwartz, and K.J. Kellar In vivo regulation of [3H]acetylcholine recognition sites in brain by nicotinic cholinergic drugs J Neurochem 45 1985 427 433 (Pubitemid 15233941)
68. R. Nashmi, and H. Lester Cell autonomy, receptor autonomy, and thermodynamics in nicotine receptor up-regulation Biochem Pharmacol 74 2007 1145 1154 (Pubitemid 47417925)
69. R. Nashmi, C. Xiao, P. Deshpande, S. McKinney, S.R. Grady, and P. Whiteaker Chronic nicotine cell specifically upregulates functional alpha 4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path J Neurosci 27 2007 8202 8218 (Pubitemid 47219619)
70. B. Buisson, and D. Bertrand Nicotine addiction: the possible role of functional upregulation Trends Pharmacol Sci 23 2002 130 136 (Pubitemid 34185414)
71. A. Lai, N. Parameswaran, M. Khwaja, P. Whiteaker, J.M. Lindstrom, and H. Fan Long-term nicotine treatment decreases striatal alpha6* nicotinic acetylcholine receptor sites and function in mice Mol Pharmacol 67 2005 1639 1647 (Pubitemid 40594163)
72. M. Mugnaini, M. Garzotti, I. Sartori, M. Pilla, P. Repeto, and C.A. Heidbreder Selective down-regulation of [(125)I]Y(0)-alpha-conotoxin MII binding in rat mesostriatal dopamine pathway following continuous infusion of nicotine Neuroscience 137 2006 565 572 (Pubitemid 43031522)
73. D.C. Perry, D. Mao, A.B. Gold, J.M. McIntosh, J.C. Pezzullo, and K.J. Kellar Chronic nicotine differentially regulates alpha6- and beta3-containing nicotinic cholinergic receptors in rat brain J Pharmacol Exp Ther 322 2007 306 315 (Pubitemid 46956379)
74. A. Kuryatov, J. Luo, J. Cooper, and J. Lindstrom Nicotine acts as a pharmacological chaperone to up-regulate human alpha4beta2 acetylcholine receptors Mol Pharmacol 68 2005 1839 1851 (Pubitemid 41654365)
75. J. Sallette, S. Pons, A. Devillers-Thiery, M. Soudant, L. Prado de Carvalho, and J.P. Changeux Nicotine upregulates its own receptors through enhanced intracellular maturation Neuron 46 2005 595 607
76. P. Tumkosit, A. Kuryatov, J. Luo, and J. Lindstrom Beta3 subunits promote expression and nicotine-induced up-regulation of human nicotinic alpha6* nicotinic acetylcholine receptors expressed in transfected cell lines Mol Pharmacol 70 2006 1358 1368 (Pubitemid 44435988)
77. H. Walsh, A.P. Govind, R. Mastro, J.C. Hoda, D. Bertrand, and Y. Vallejo Upregulation of nicotinic receptors by nicotine varies with receptor subtype J Biol Chem 283 2008 6022 6032
78. R. Polosa, and N.L. Benowitz Treatment of nicotine addiction: present therapeutic options and pipeline developments Trends Pharmacol Sci 79 2011 281 289
79. S. Rahman Brain nicotinic receptors as emerging targets for drug addiction neurobiology to translational research Prog Mol Biol Trans Sci 98 2011 349 365
80. J.P. Changeux Nicotine addiction and nicotinic receptors: lessons from genetically modified mice Nat Rev Neurosci 11 2010 389 401
81. N.L. Benowitz Nicotine addiction N Engl J Med 362 2010 2295 2303
82. W.A. Corrigall, K.M. Coen, and K.L. Adamson Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area Brain Res 653 1994 278 284 (Pubitemid 24252850)
83. W.A. Corrigall, K.B. Franklin, K.M. Coen, and P.B. Clarke The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine Psychopharmacology (Berl) 107 1992 285 289
84. S.R. Goldberg, and J.E. Henningfield Reinforcing effects of nicotine in humans and experimental animals responding under intermittent schedules of i.v. drug injection Pharmacol Biochem Behav 30 1988 227 234 (Pubitemid 19268815)
85. M.R. Picciotto, and W.A. Corrigall Neuronal systems underlying behaviors related to nicotine addiction: neural circuits and molecular genetics J Neurosci 22 2002 3338 3341 (Pubitemid 37465738)
86. C.D. Fowler, M.A. Arends, and P.J. Kenny Subtypes of nicotinic acetylcholine receptors in nicotine reward, dependence, and withdrawal: evidence from genetically modified mice Behav Pharmacol 19 2008 461 484
87. D.J. Balfour The neuronal pathways mediating the behavioral and addictive properties of nicotine Handb Exp Pharmacol 2009 209 233
88. M.R. Picciotto, M. Zoli, R. Rimondini, C. Lena, L.M. Marubio, and E.M. Pich Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine Nature 391 1998 173 177 (Pubitemid 28092475)
89. U. Maskos, B.E. Molles, S. Pons, M. Besson, B.P. Guiard, and J.P. Guilloux Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors Nature 436 2005 103 107 (Pubitemid 40966193)
90. A.R. Tapper, S.L. McKinney, R. Nashmi, J. Schwarz, P. Deshpande, and C. Labarca Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization Science 306 2004 1029 1032 (Pubitemid 39482905)
91. S. Pons, L. Fattore, G. Cossu, S. Tolu, E. Porcu, and J.M. McIntosh Crucial role of alpha4 and alpha6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration J Neurosci 28 2008 12318 12327
92. D.H. Brunzell, K.E. Boschen, E.S. Hendrick, P.M. Beardsley, and J.M. McIntosh alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors in the nucleus accumbens shell regulate progressive ratio responding maintained by nicotine Neuropsychopharmacology 35 2010 665 673
93. K.J. Jackson, J.M. McIntosh, D.H. Brunzell, S.S. Sanjakdar, and M.I. Damaj The role of {alpha}6-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal J Pharmacol Exp Ther 331 2009 547 554
94. R.M. Drenan, S.R. Grady, A.D. Steele, S. McKinney, N.E. Patzlaff, and J.M. McIntosh Cholinergic modulation of locomotion and striatal dopamine release is mediated by {alpha}6{alpha}4* nicotinic acetylcholine receptors J Neurosci 30 2010 9877 9889
95. R. Zhao-Shea, L. Liu, L.G. Soll, M.R. Improgo, E.E. Meyers, and J.M. McIntosh Nicotine-mediated activation of dopaminergic neurons in distinct regions of the ventral tegmental area Neuropsychopharmacology 36 2011 1021 1032
96. M. Besson, S. Granon, M. Mameli-Engvall, I. Cloez-Tayarani, N. Maubourguet, and A. Cormier Long-term effects of chronic nicotine exposure on brain nicotinic receptors Proc Natl Acad Sci USA 104 2007 8155 8160 (Pubitemid 47185891)
97. B. Soderpalm, E. Lof, and M. Ericson Mechanistic studies of ethanol's interaction with the mesolimbic dopamine reward system Pharmacopsychiatry 42 Suppl. 1 2009 S87 S94
98. K.B. Mihalak, F.I. Carroll, and C.W. Luetje Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors Mol Pharmacol 70 2006 801 805 (Pubitemid 44268437)
99. Quik M. unpublished observation.
100. S.R. Grady, R.M. Drenan, S.R. Breining, D. Yohannes, C.R. Wageman, and N.B. Fedorov Structural differences determine the relative selectivity of nicotinic compounds for native alpha 4 beta 2*-, alpha 6 beta 2*-, alpha 3 beta 4*- and alpha 7-nicotine acetylcholine receptors Neuropharmacology 58 2010 1054 1066
101. P. Steensland, J.A. Simms, J. Holgate, J.K. Richards, and S.E. Bartlett Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking Proc Natl Acad Sci USA 104 2007 12518 12523 (Pubitemid 47206170)
102. E. Lof, P. Olausson, A. Debejczy, R. Stomberg, J.M. McIntosh, and J.R. Taylor Nicotinic acetylcholine receptors in the ventral tegmental area mediate the dopamine activating and reinforcing properties of ethanol cues Psychopharmacology (Berl) 195 2007 333 343 (Pubitemid 350160265)
103. L.M. Hendrickson, P. Gardner, and A.R. Tapper Nicotinic acetylcholine receptors containing the alpha4 subunit are critical for the nicotine-induced reduction of acute voluntary ethanol consumption Channels (Austin) 2011 5
104. S.A. McKee, E.L. Harrison, S.S. O'Malley, S. Krishnan-Sarin, J. Shi, and J.M. Tetrault Varenicline reduces alcohol self-administration in heavy-drinking smokers Biol Psychiatry 66 2009 185 190
105. L.M. Hendrickson, R. Zhao-Shea, X. Pang, P.D. Gardner, and A.R. Tapper Activation of alpha4* nAChRs is necessary and sufficient for varenicline-induced reduction of alcohol consumption J Neurosci 30 2010 10169 10176
106. S. Chatterjee, P. Steensland, J.A. Simms, J. Holgate, J.W. Coe, and R.S. Hurst Partial agonists of the alpha3beta4* neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats Neuropsychopharmacology 36 2011 603 615
107. A. Larsson, E. Jerlhag, L. Svensson, B. Soderpalm, and J.A. Engel Is an alpha-conotoxin MII-sensitive mechanism involved in the neurochemical, stimulatory, and rewarding effects of ethanol? Alcohol 34 2004 239 250 (Pubitemid 40292783)
108. N. le Novere, M. Zoli, C. Lena, R. Ferrari, M.R. Picciotto, and E. Merlo-Pich Involvement of alpha6 nicotinic receptor subunit in nicotine-elicited locomotion, demonstrated by in vivo antisense oligonucleotide infusion Neuroreport 10 1999 2497 2501 (Pubitemid 29418126)
109. R.M. Drenan, S.R. Grady, P. Whiteaker, T. McClure-Begley, S. McKinney, and J.M. Miwa In vivo activation of midbrain dopamine neurons via sensitized, high-affinity alpha 6 nicotinic acetylcholine receptors Neuron 60 2008 123 136
110. L.M. Marubio, A.M. Gardier, S. Durier, D. David, R. Klink, and M.M. Arroyo-Jimenez Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors Eur J Neurosci 17 2003 1329 1337 (Pubitemid 36560833)
111. E. Jerlhag, E. Egecioglu, S.L. Dickson, L. Svensson, and J.A. Engel Alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors are involved in mediating the ghrelin-induced locomotor stimulation and dopamine overflow in nucleus accumbens Eur Neuropsychopharmacol 18 2008 508 518
112. M. Quik, Y. Polonskaya, A. Gillespie, K.G. Lloyd, and J.W. Langston Differential alterations in nicotinic receptor alpha6 and beta3 subunit messenger RNAs in monkey substantia nigra after nigrostriatal degeneration Neuroscience 100 2000 63 72 (Pubitemid 30670302)
113. M. Quik, J.D. Sum, P. Whiteaker, S.E. McCallum, M.J. Marks, and J. Musachio Differential declines in striatal nicotinic receptor subtype function after nigrostriatal damage in mice Mol Pharmacol 63 2003 1169 1179 (Pubitemid 36529935)
114. J.M. Kulak, J.M. McIntosh, and M. Quik Loss of nicotinic receptors in monkey striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment is due to a decline in alpha-conotoxin MII sites Mol Pharmacol 61 2002 230 238 (Pubitemid 34049531)
115. I.J. Bohr, M.A. Ray, J.M. McIntosh, S. Chalon, D. Guilloteau, and I.G. McKeith Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases. An autoradiography study using [(125)I]alpha-conotoxinMII in the striatum and thalamus Exp Neurol 191 2005 292 300 (Pubitemid 40092872)
116. C. Gotti, M. Moretti, I. Bohr, I. Ziabreva, S. Vailati, and R. Longhi Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease. Parkinson's disease and dementia with Lewy bodies by immunoprecipitation Neurobiol Dis 23 2006 481 489 (Pubitemid 44097037)
117. M. Quik, T. Bordia, L. Forno, and J.M. McIntosh Loss of alpha-conotoxinMII- and A85380-sensitive nicotinic receptors in Parkinson's disease striatum J Neurochem 88 2004 668 679 (Pubitemid 38140211)
118. M. Quik, M. O'Neill, and X.A. Perez Nicotine neuroprotection against nigrostriatal damage: importance of the animal model Trends Pharmacol Sci 28 2007 229 235 (Pubitemid 46680334)
119. M.J. O'Neill, T.K. Murray, V. Lakics, N.P. Visanji, and S. Duty The role of neuronal nicotinic acetylcholine receptors in acute and chronic neurodegeneration Curr Drug Target CNS Neurol Disord 1 2002 399 411
120. M.R. Picciotto, and M. Zoli Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease Front Biosci 13 2008 492 504 (Pubitemid 351599760)
121. L.Z. Huang, N. Parameswaran, T. Bordia, J. Michael McIntosh, and M. Quik Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys J Neurochem 109 2009 826 837
122. A.H. Schapira, M. Emre, P. Jenner, and W. Poewe Levodopa in the treatment of Parkinson's disease Eur J Neurol 16 2009 982 989
123. W. Poewe Treatments for Parkinson disease - past achievements and current clinical needs Neurology 72 2009 S65 S73
124. A.E. Lang When and how should treatment be started in Parkinson disease? Neurology 72 2009 S39 S43
125. S. Fahn How do you treat motor complications in Parkinson's disease: medicine, surgery, or both? Ann Neurol 64 2009 S56 S64
126. G. Pezzoli, and M. Zini Levodopa in Parkinson's disease: from the past to the future Expert Opin Pharmacother 11 2010 627 635
127. J.E. Ahlskog, and M.D. Muenter Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature Mov Disord 16 2001 448 458 (Pubitemid 36041148)
128. Huang LZ, Bordia T, Quik M. Nicotine treatment reduces l-dopa-induced dyskinetic-like movements in parkinsonian mice. Society for Neuroscience Abstracts; 2009.
129. T. Bordia, C. Campos, L. Huang, and M. Quik Continuous and intermittent nicotine treatment reduces L-3,4-dihydroxyphenylalanine (l-DOPA)-induced dyskinesias in a rat model of Parkinson's disease J Pharmacol Exp Ther 327 2008 239 247
130. M. Quik, H. Cox, N. Parameswaran, K. O'Leary, J.W. Langston, and D. Di Monte Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys Ann Neurol 62 2007 588 596
131. T. Bordia, C. Campos, J.M. McIntosh, and M. Quik Nicotinic receptor-mediated reduction in l-dopa-induced dyskinesias may occur via desensitization J Pharmacol Exp Ther 333 2010 929 938
132. H. Rollema, J.W. Coe, and L.K. Chambers Rationale, pharmacology and clinical efficacy of partial agonists of alpha(4)beta(2) nACh receptors for smoking cessation Trends Pharmacol Sci 28 2007 316 325 (Pubitemid 47016686)
133. J.M. Kulak, J. Sum, J.L. Musachio, J.M. McIntosh, and M. Quik 5-Iodo-A-85380 binds to alpha-conotoxin MII-sensitive nicotinic acetylcholine receptors (nAChRs) as well as alpha4beta2* subtypes J Neurochem 81 2002 403 406 (Pubitemid 34809365)
134. L.Z. Huang, C. Campos, J. Ly, F.I. Carroll, and M. Quik Nicotinic receptor agonists decrease l-dopa-induced dyskinesias most effectively in moderately lesioned parkinsonian rats Neuropharmacology 60 2011 861 868
135. A.R. Carta, L. Frau, S. Pontis, A. Pinna, and M. Morelli Direct and indirect striatal efferent pathways are differentially influenced by low and high dyskinetic drugs: behavioural and biochemical evidence Parkinsonism Relat Disord 14 Suppl. 2 2008 S165 S168
136. M. Carta, T. Carlsson, A. Munoz, D. Kirik, and A. Bjorklund Involvement of the serotonin system in l-dopa-induced dyskinesias Parkinsonism Relat Disord 14 Suppl. 2 2008 S154 S158
137. M.A. Cenci, and C. Konradi Maladaptive striatal plasticity in l-DOPA-induced dyskinesia Prog Brain Res 183C 2010 209 233
138. P. Limousin, and I. Martinez-Torres Deep brain stimulation for Parkinson's disease Neurotherapeutics 5 2008 309 319 (Pubitemid 351446211)
139. Z. Xiang, J.R. Huguenard, and D.A. Prince Cholinergic switching within neocortical inhibitory networks Science 281 1998 985 988 (Pubitemid 28399247)
140. H. Morishita, J.M. Miwa, N. Heintz, and T.K. Hensch Lynx1, a cholinergic brake, limits plasticity in adult visual cortex Science 330 2010 1238 1240
141. O. Salminen, K.L. Murphy, J.M. McIntosh, J. Drago, M.J. Marks, and A.C. Collins Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice Mol Pharmacol 65 2004 1526 1535 (Pubitemid 38668310)
142. C.W. Luetje Getting past the asterisk: the subunit composition of presynaptic nicotinic receptors that modulate striatal dopamine release Mol Pharmacol 65 2004 1333 1335 (Pubitemid 38668291)